MedTrace Logo

High Coverage CARotid Stenting vs. Medical Management Alone to Prevent EmboliSm From symptomaTic Non-stenotic cARotid Disease (SyNC)

NCT07166731 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 536

Last updated 2026-03-04

No results posted yet for this study

Summary

Goal is to analyse the clinical safety and efficacy of the CARESTO® heal Stent within standard clinical routine for the treatment of patients with symptomatic non-stenotic carotid disease (SyNC) and with high-risk plaque features for stroke recurrence compared to medical treatment alone with respect to the mid- and long-term clinical outcomes.

Conditions

  • Carotid Artery Disease
  • Symptomatic Carotid Artery Stenosis
  • Carotid Artery Stenting
  • Carotid Plaque Imaging
  • Embolic Stroke of Undetermined Source
  • Carotid Artery Thrombosis

Sponsors & Collaborators

  • Acandis GmbH

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-01
Primary Completion
2032-05-31
Completion
2032-06-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07166731 on ClinicalTrials.gov